Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2510]

Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity

Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and...

New research uncovers how common genetic mutation drives cancer

New research uncovers how common genetic mutation drives cancer

E-cigarette smoke caused lung cancer in mice

E-cigarette smoke caused lung cancer in mice

Organoid technology and single-cell sequencing to advance in the study of bladder cancer

Organoid technology and single-cell sequencing to advance in the study of bladder cancer

Gut bacteria 'fingerprint' predicts radiotherapy side effects

Gut bacteria 'fingerprint' predicts radiotherapy side effects

Biomarker in urine may offer non-invasive detection of prostate cancer

Biomarker in urine may offer non-invasive detection of prostate cancer

ESMO 2019: Breast and ovarian cancer drug outperforms targeted hormone therapy in some men

ESMO 2019: Breast and ovarian cancer drug outperforms targeted hormone therapy in some men

Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer

Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated...

ESMO 2019: Targeted therapy slows progression of advanced prostate cancer

ESMO 2019: Targeted therapy slows progression of advanced prostate cancer

ESMO 2019: Adding immunotherapy to chemotherapy prolongs progression free survival in bladder cancer

ESMO 2019: Adding immunotherapy to chemotherapy prolongs progression free survival in bladder cancer

More from ecancer